A detailed history of Group One Trading, L.P. transactions in Axogen, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,315 shares of AXGN stock, worth $20,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,315
Previous 1,525 13.77%
Holding current value
$20,566
Previous $11,000 63.64%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $14.69 $1,579 - $3,084
-210 Reduced 13.77%
1,315 $18,000
Q2 2024

Aug 14, 2024

SELL
$5.67 - $8.06 $317 - $451
-56 Reduced 3.54%
1,525 $11,000
Q1 2024

May 10, 2024

BUY
$6.63 - $10.69 $10,482 - $16,900
1,581 New
1,581 $12,000
Q2 2022

Aug 11, 2022

SELL
$6.99 - $10.0 $699 - $1,000
-100 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$17.18 - $22.6 $1,718 - $2,260
100 New
100 $2,000
Q3 2020

Nov 12, 2020

SELL
$10.62 - $13.12 $14,538 - $17,961
-1,369 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$7.35 - $10.81 $10,062 - $14,798
1,369 New
1,369 $13,000
Q4 2019

Feb 10, 2020

SELL
$11.18 - $18.6 $21,946 - $36,511
-1,963 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$12.09 - $20.46 $23,732 - $40,162
1,963 New
1,963 $25,000
Q2 2019

Aug 09, 2019

SELL
$18.5 - $25.47 $24,808 - $34,155
-1,341 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$14.62 - $22.13 $16,754 - $25,360
-1,146 Reduced 46.08%
1,341 $28,000
Q4 2018

Feb 06, 2019

BUY
$17.09 - $38.25 $42,502 - $95,127
2,487 New
2,487 $51,000
Q2 2018

Aug 14, 2018

SELL
$36.15 - $52.5 $18,075 - $26,250
-500 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$24.4 - $40.25 $12,200 - $20,125
500 New
500 $18,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.